CA Patent

CA2760040A1 — Dry-processing of retigabine

Assigned to Ratiopharm GmbH · Expires 2010-09-23 · 16y expired

What this patent protects

The invention relates to dry processes for the production of oral dosage forms, espe-cially tablets, containing retigabine and adhesion promoter. In addition, the invention relates to compacted intermediates containing retigabine and an adhesion promoter. Finally, the invention …

USPTO Abstract

The invention relates to dry processes for the production of oral dosage forms, espe-cially tablets, containing retigabine and adhesion promoter. In addition, the invention relates to compacted intermediates containing retigabine and an adhesion promoter. Finally, the invention relates to single-dose and multiple-dose containers, preferably sachets and stick-packs, containing the intermediate of the invention.

Drugs covered by this patent

Patent Metadata

Patent number
CA2760040A1
Jurisdiction
CA
Classification
—
Expires
2010-09-23
Drug substance claim
No
Drug product claim
No
Assignee
Ratiopharm GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.